InvestorsHub Logo
Followers 29
Posts 2189
Boards Moderated 1
Alias Born 05/09/2013

Re: patientlywaiting post# 293203

Saturday, 04/01/2017 8:59:52 AM

Saturday, April 01, 2017 8:59:52 AM

Post# of 346191
Yeah its also KITE pharmaceuticals that were probably the company along with JUNO that CAR T was about last night on ABC news. Though they didn't mention any specific companies I looked at AH share price on kITE and it spiked $2 once that segment was shown. ABC was covering Lymphoma, so I figure its KITE by this announcement.

https://finance.yahoo.com/news/kite-completes-submission-u-biologics-191500909.html

Understanding that these morons running the show never partnered with a BP, while KITE and JUNO (CELG) both did, while literally receiving $1B in funding our little scratcher (Like a lottery ticket) is probably to far behind. I also have a feeling the Exosome test is the same way. Always the bridesmaid and never the bride.

I will say they spoke about the Moffitt cancer center and CAR T as if it was already in prime time with patients. Look at KITE and they have all the paper work in place with the FDA. They made an announcement AH's and the company (didn't mention the name) on ABC news had gained Fast Track status.

Who knows as we get excited about all the puzzle pieces, but there is a lot going on in this space. Who is winning and who will get the center stage? I don't know, but from reading this board we will have a place because of our differentiator. Yet I often wonder if our inability to partner will have us left at the alter. If we had partnered 3 years ago imagine where we would have been at this point?

Well this coming week will be interesting and lets hope not disappointing. I'm hoping we can pop over $1 and RS is averted otherwise PPHM will probably be a 2018 story at the earliest. Always next year. Eyeore!!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News